Patrizio Armeni

Patrizio Armeni is Associate Professor of Practice in Government, Health and Not for Profit at SDA Bocconi School of Management.

Patrizio’s collaboration with SDA Bocconi started in 2009. He has gradually widened the scope of his research and teaching which began withthe Osservatorio Farmaci (Pharmaceutical Observatory) and went on to include, over time, other research areas related to public management, with a particular focus on the healthcare sector. His knowledge of healthcare organizations has awakened his interest in studying organizational behaviors of individuals and teams and led him to adopt an educational approach based on the daily practice of ethical principles in the workplace (leadership in practice).

He has directed various executive programs for employees of pharmaceutical and medical device companies and has coordinated several sponsored educational programs dedicated to physicians and other healthcare and public sector professionals. He supervises a category of open market courses including programs dedicated to the interaction between the national health service and technology providers (pharma, medical devices, services). He also teaches «Public Management» and «Innovation and competition in life science» at undergraduate level, and several courses on national and international master programs: «Economics of healthcare organizations», «Pharmaceutical policy», «Economic Evaluations - advanced» and «Evidence-based health policy evaluation», «Policy Evaluation».

He coordinates the research area «Health Economics & HTA» at CERGAS (Center for Research on Health and Social Care Management) at SDA Bocconi. His current research activity is focused on three themes: 1) economic evaluations of healthcare technologies (cost-effectiveness, cost-utility and budget impact analysis) and related methodological developments founded on the pillar of value-based healthcare; 2) analysis and support for policymakers for public policy design and implementation; 3) analysis of pharmaceutical and health technology markets in terms of performance, innovation and reaction to public policies. He has published several articles in international peer-reviewed journals and is the author of a number of chapters in monographic works. Since 2009 he has authored the chapter on healthcare expenditure in the OASI (Observatory on Healthcare Organizations and Policies in Italy) report, the leading annual Italian publication on issues relating to the healthcare system. He is member of the editorial board of the OASI report. Since 2020 he was appointed as director of operation of the newborn “LIFT” Lab dedicated to the convergence between digital innovation and life sciences.

Patrizio’s production and diffusion of knowledge is coupled with frequent participation as a speaker in international and national congresses and conferences. He serves as an expert on advisory boards for companies operating in the pharmaceutical / medical.

Teaching domains

• Economic Evaluations of Drugs
• Health Technology Assessment
• Policy Impact Analysis
• Real-World Data and Real-World Evidence
• Self-Leadership

Education

• Doctor of Philosophy - PhD Università Bocconi (2011 — 2017)
• Laurea specialistica LUISS GUIDO CARLI (2006 — 2007)
• Laurea Triennale Luiss Giudo Carli (2002 — 2005)

Latest publications

• ARMENI P., BERTOLANI A., BORSOI L., COSTA F.
  La spesa sanitaria: composizione ed evoluzione in Rapporto OASI 2021
  CERGAS (Eds),Egea, chap. 3, pp.117-173, 2021
  
• ARMENI P., MEREGAGLIA M., BORSOI L., TORBICA A., CALLEA G.
  PMD16 What Factors Do Clinicians Value Most in Selecting Physician Preference Items? a Survey in Orthopedics Using Discrete Choice Experiment and Best-Worst Scaling
  Value in Health, 2021, vol.24, pp.S126
  
• TARRICONE R., AMATUCCI F., ARMENI P., BANKS H., BORSOI L., CALLEA G., CIANI O., COSTA F., FEDERICI C. B., TORBICA A., MARLETTA M.
  Establishing a national HTA program for medical devices in Italy: Overhauling a fragmented system to ensure value and equal access to new medical technologies
  Health Policy, 2021, vol.125, no. 5, pp.602-608
  
• ARMENI P., CAVAZZA M., XOXI E., TARUSCIO D., KODRA Y.
  Reflections on the Importance of Cost of Illness Analysis in Rare Diseases: A Proposal
  International Journal of Environmental Research and Public Health, 2021, vol.18, no. 3, pp.1101
• JOMMI C., ARMENI P., BERTOLANI A., COSTA F., OTTO M.
  The future of Funds for Innovative Medicines: results from a Delphi Study
  Global & Regional Health Technology Assessment: Italian; Northern Europe and Spanish, 2021, vol.8, pp.22-28
  
• KODRA Y., CAVAZZA M., DE SANTIS M., GUALA A., LIVERANI M., ARMENI P., MASINI M., TARUSCIO D.
  Social Economic Costs, Health-Related Quality of Life and Disability in Patients with Cri Du Chat Syndrome
  International Journal of Environmental Research and Public Health, 2020, vol.17, no. 16, pp.5951